Clinical and patient reported outcomes in multiple sclerosis patients on disease modifying therapies

被引:0
|
作者
Fernandes, L. [1 ]
Horton, M. [2 ]
Russell, M. [1 ]
Lily, O. [1 ]
Ford, H. L. [1 ]
机构
[1] Leeds Teaching Hosp NHS Trust, Leeds Ctr Neurosci, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P812
引用
收藏
页码:417 / 418
页数:2
相关论文
共 50 条
  • [11] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
  • [12] A systematic literature review of the measurement of patient-reported fatigue in studies of disease modifying therapies for multiple sclerosis
    Le, Hoa H.
    Stocks, S. Jill
    Ait-Tihyaty, Maria
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 91
  • [13] Effects of multiple sclerosis disease-modifying therapies on employment measures using patient-reported data
    Chen, Jing
    Taylor, Bruce V.
    Blizzard, Leigh
    Simpson, Steve, Jr.
    Palmer, Andrew J.
    van der Mei, Ingrid A. F.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (11): : 1200 - 1207
  • [14] A Systematic Literature Review of the Measurement of Patient-Reported Fatigue in Studies of Disease Modifying Therapies for Multiple Sclerosis
    Le, H. H.
    Stock, S.
    Ait-Tihyaty, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 197 - 198
  • [15] Impact of Treatment Adherence on Clinical and Economic Outcomes among Multiple Sclerosis Patients Receiving Disease-Modifying Therapies
    Tan, Hiangkiat
    Cai, Qian
    Agarwal, Sonalee S.
    Kamat, Siddhesh A.
    NEUROLOGY, 2010, 74 (09) : A365 - A365
  • [16] Pregnancy Outcomes in Multiple Sclerosis patients with or without exposure to Disease Modifying Therapies during pregnancy
    Bast, Nadine
    Thiel, Sandra
    Haben, Sabrina
    Ciplea, Andrea
    Hellwig, Kerstin
    Gold, Ralf
    NEUROLOGY, 2023, 100 (17)
  • [17] Disease modifying therapies in multiple sclerosis - Reply
    Goodin, DS
    NEUROLOGY, 2002, 59 (03) : 472 - 473
  • [18] Disease modifying therapies for relapsing multiple sclerosis
    Wingerchuk, Dean M.
    Weinshenker, Brian G.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [19] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [20] RANKING OF DISEASE -MODIFYING THERAPIES FOR MULTIPLE SCLEROSIS
    Fogarty, E.
    Schmitz, S.
    Walsh, C.
    Barry, M.
    VALUE IN HEALTH, 2015, 18 (07) : A750 - A750